Getinge Receives FDA Clearance for Surgical Tools, Prepares for U.S. Launch

Getinge, headquartered in Gothenburg, Sweden, recently obtained significant FDA clearance for its range of surgical tools, marking the beginning of its U.S. launch. Among the cleared products is the Vasoview Hemopro 3, an addition to Getinge's endoscopic vessel harvesting (EVH) solutions portfolio. Engineered with customer-centric design principles, the Vasoview Hemopro 3 aims to enhance procedural efficiency, featuring advanced functionalities such as smoke evacuation, energy control regulation, ergonomic handle design, and integrated cabling. The company plans to introduce this product in the U.S. market in the third quarter of 2024, while regulatory submissions for approval in other key markets are ongoing.

In addition to the Vasoview Hemopro 3, Getinge unveiled the Maquet Corin OR table and Ezea surgical light, designed to streamline workflows in surgical departments. The Maquet Corin OR table, equipped with smart, mobile capabilities, boasts advanced feedback lighting, intuitive controls, and safety features including collision detection and tipping prevention, prioritizing patient and staff safety. Meanwhile, the Ezea surgical light offers customizable user sequences and preset surgical positions to enhance flexibility and efficiency in patient positioning. Getinge aims to address challenges in operating room management while providing surgeons and staff with impactful solutions that prioritize safety and efficiency in surgical procedures.

Become a Subscriber

Please purchase a subscription to continue reading this article.

Subscribe Now

Read more